In2Bones' ortho planning software gets FDA nod

By staff writers

September 1, 2021 -- Bone and joint restoration product manufacturer In2Bones has received clearance from the U.S. Food and Drug Administration (FDA) for its Orthoplanify orthopedic surgical planning software and 3D cutting guides.

The software integrates patient CT scans and x-rays, enabling surgeons to modify, adjust, and manipulate the placement of In2Bones' Quantum total ankle system implant prior to surgery. During surgery, the system's 3D-printed cutting guides aim to allow for precision bone cuts and more accurate implant alignment.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking